Bravo Multinational Reports $210K Loss, $2.3K Cash, and Material Weakness
BRVO is trading near its 52-week low of $0.017 (12% above the low) on elevated volume (5.4× avg).
Summary
Bravo Multinational's Q2 2026 10-Q shows a $210,071 six-month net loss, only $2,319 in cash, and a material weakness in internal controls, reinforcing going concern doubts.
Key Events · Earnings and Guidance · BRVO
-
Net Loss Widens
Six-month net loss of $210,071, up from $140,055 in the prior year period, driven by higher board fees and professional fees.
-
Cash Position Critical
Cash of only $2,319 at June 30, 2026, with total liabilities of $1,175,075 and a working capital deficit of $1,172,756.
-
Material Weakness Disclosed
Management identified inadequate segregation of duties in cash disbursement and financial reporting, constituting a material weakness in internal control over financial reporting.
-
Going Concern Reiterated
The company states substantial doubt about its ability to continue as a going concern, with no revenue and reliance on related-party financing.
Analysis · BRVO · Trade & Services
The 10-Q reveals a company with essentially no cash ($2,319), a working capital deficit of $1.17 million, and a material weakness in internal controls. The going concern warning is reiterated, and the company has no revenue. The resignation payment to Kayla Slick adds $25,000 in cash obligations and 150,000 shares. This is a critical financial health update for a micro-cap stock.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BRVO was trading at $0.02 on OTC in the Trade & Services sector, with a market capitalization of approximately $903.8K. The 52-week trading range was $0.02 to $0.15. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.